-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QUsIDzHmBy1DhZ6PFbeY0JhNmP/bVP5/rzYrV8NjyV555wsOG23ECihYrz4Vc78D Z7KI6fQC77xDbMrAllbDGg== 0001181431-06-006204.txt : 20060127 0001181431-06-006204.hdr.sgml : 20060127 20060127184554 ACCESSION NUMBER: 0001181431-06-006204 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060125 FILED AS OF DATE: 20060127 DATE AS OF CHANGE: 20060127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OMENN GILBERT S CENTRAL INDEX KEY: 0001184227 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 06559654 BUSINESS ADDRESS: STREET 1: AMGEN INC STREET 2: ONE AMGEN CENTER DR CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 BUSINESS PHONE: 805-447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE STREET 2: MAIL STOP 27-3-C CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4 1 rrd104941.xml FORM 4 X0202 4 2006-01-25 0 0000318154 AMGEN INC AMGN 0001184227 OMENN GILBERT S ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 0 0 0 CCPR 0.5 D Common Stock 2006-01-25 4 M 0 9600 14.7188 A 177542 D Common Stock 2006-01-25 4 F 0 1885 74.9399 D 175657 D NQSO (Right to Buy) 14.7188 2006-01-25 4 M 0 9600 14.7188 D 1997-01-29 2006-01-29 Common Stock 9600 0 D (GO-CCPR) Contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. The reporting person no longer has a reportable beneficial interest in 5,590 shares of Amgen Inc. common stock owned by his son and included in the reporting person's prior ownership reports. /s/ N. Cris Prince Attorney-In-Fact 2006-01-27 -----END PRIVACY-ENHANCED MESSAGE-----